Israel Englander’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.1M | Buy |
3,309,122
+50,931
| +2% | +$152K | ﹤0.01% | 2270 |
|
|
2026
Q1 | $10M | Buy |
3,258,191
+3,050,808
| +1,471% | +$13M | ﹤0.01% | 2165 |
|
|
2025
Q4 | $749K | Sell |
207,383
-160,199
| -44% | -$698K | ﹤0.01% | 4673 |
|
|
2025
Q3 | $1.39M | Buy |
367,582
+289,288
| +369% | +$1.12M | ﹤0.01% | 4360 |
|
|
2025
Q2 | $303K | Sell |
78,294
-1,033,005
| -93% | -$5.59M | ﹤0.01% | 5187 |
|
|
2025
Q1 | $5.56M | Buy |
1,111,299
+765,662
| +222% | +$4.85M | ﹤0.01% | 2749 |
|
|
2024
Q4 | $2.49M | Buy |
345,637
+241,484
| +232% | +$1.84M | ﹤0.01% | 3449 |
|
|
2024
Q3 | $639K | Buy |
104,153
+90,798
| +680% | +$615K | ﹤0.01% | 4625 |
|
|
2024
Q2 | $88.8K | Sell |
13,355
-1,576,795
| -99% | -$11.6M | ﹤0.01% | 5329 |
|
|
2024
Q1 | $16.2M | Buy |
1,590,150
+1,416,009
| +813% | +$14.4M | 0.01% | 1731 |
|
|
2023
Q4 | $1.96M | Buy |
174,141
+76,908
| +79% | +$321K | ﹤0.01% | 3621 |
|
|
2023
Q3 | $253K | Sell |
97,233
-844,861
| -90% | -$2.42M | ﹤0.01% | 5013 |
|
|
2023
Q2 | $3.33M | Sell |
942,094
-126,651
| -12% | -$569K | ﹤0.01% | 3040 |
|
|
2023
Q1 | $4.51M | Buy |
1,068,745
+924,007
| +638% | +$11M | ﹤0.01% | 2698 |
|
|
2022
Q4 | $2.38M | Sell |
144,738
-360,989
| -71% | -$4.05M | ﹤0.01% | 3434 |
|
|
2022
Q3 | $6.46M | Sell |
505,727
-318,921
| -39% | -$4.71M | ﹤0.01% | 2646 |
|
|
2022
Q2 | $9.65M | Buy |
824,648
+127,488
| +18% | +$786K | 0.01% | 2084 |
|
|
2022
Q1 | $4.25M | Buy |
697,160
+588,302
| +540% | +$4.33M | ﹤0.01% | 3113 |
|
|
2021
Q4 | $997K | Sell |
108,858
-29,396
| -21% | -$312K | ﹤0.01% | 4414 |
|
|
2021
Q3 | $1.56M | Buy |
+138,254
| New | +$1.68M | ﹤0.01% | 4188 |
|
|
2021
Q2 | – | Sell |
-732,742
| Closed | -$10M | – | 6474 |
|
|
2021
Q1 | $10.4M | Buy |
732,742
+355,554
| +94% | +$5.75M | 0.01% | 1737 |
|
|
2020
Q4 | $4.25M | Buy |
377,188
+98,945
| +36% | +$1.17M | ﹤0.01% | 2595 |
|
|
2020
Q3 | $3.67K | Sell |
278,243
-228,281
| -45% | -$4.56M | ﹤0.01% | 2094 |
|
|
2020
Q2 | $5.42M | Buy |
+506,524
| New | +$2.78M | 0.01% | 1693 |
|
|
2018
Q2 | – | Sell |
-547
| Closed | -$19K | – | 3763 |
|
|
2018
Q1 | $19K | Sell |
547
-1,592
| -74% | -$79.8K | ﹤0.01% | 3567 |
|
|
2017
Q4 | $128K | Sell |
2,139
-613
| -22% | -$39.2K | ﹤0.01% | 3617 |
|
|
2017
Q3 | $192K | Sell |
2,752
-783
| -22% | -$58.3K | ﹤0.01% | 3257 |
|
|
2017
Q2 | $339K | Buy |
+3,535
| New | +$588K | ﹤0.01% | 2995 |
|
|
2017
Q1 | – | Sell |
-177
| Closed | -$173K | – | 3454 |
|
|
2016
Q4 | $173K | Buy |
+177
| New | +$159K | ﹤0.01% | 3116 |
|
Other funds holding ALT
DTC
TCM
RCM
Israel Englander's ALT Position: Q2 2026 in Review
Israel Englander increased its Altimmune (ALT) stake by 1.6% in Q2 2026, buying an estimated $152K and bringing the position to 3,309,122 shares worth $10.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2270.
Israel Englander first reported a position in ALT in Q4 2016 and has held it in 29 quarters since. The position peaked at $16.2M in Q1 2024. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.
- Israel Englander held 3,309,122 shares of Altimmune worth $10.1M as of Q2 2026.
- Israel Englander bought 50,931 Altimmune shares in Q2 2026, an estimated $152K.
- Altimmune made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2270 holding.
- Israel Englander first reported a position in Altimmune in Q4 2016 and has held it in 29 quarters since.
- Israel Englander's Altimmune position peaked at $16.2M in Q1 2024.
- 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.